- Home
- WHWK vs GRCE Comparison
WHWK vs GRCE Comparison
Compare WHWK & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- GRCE
- Stock Information
- Founded
- WHWK 2007
- GRCE 2002
- Country
- WHWK United States
- GRCE United States
- Employees
- WHWK N/A
- GRCE N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- GRCE
- Sector
- WHWK Health Care
- GRCE
- Exchange
- WHWK Nasdaq
- GRCE NYSE
- Market Cap
- WHWK 48.3M
- GRCE 40.0M
- IPO Year
- WHWK N/A
- GRCE N/A
- Fundamental
- Price
- WHWK $1.87
- GRCE $2.97
- Analyst Decision
- WHWK
- GRCE Strong Buy
- Analyst Count
- WHWK 0
- GRCE 1
- Target Price
- WHWK N/A
- GRCE $12.00
- AVG Volume (30 Days)
- WHWK 100.5K
- GRCE 18.1K
- Earning Date
- WHWK 05-08-2025
- GRCE 06-17-2025
- Dividend Yield
- WHWK N/A
- GRCE N/A
- EPS Growth
- WHWK N/A
- GRCE N/A
- EPS
- WHWK 0.91
- GRCE N/A
- Revenue
- WHWK $27,775,000.00
- GRCE N/A
- Revenue This Year
- WHWK $40.15
- GRCE N/A
- Revenue Next Year
- WHWK N/A
- GRCE N/A
- P/E Ratio
- WHWK $2.01
- GRCE N/A
- Revenue Growth
- WHWK 16.51
- GRCE N/A
- 52 Week Low
- WHWK $1.21
- GRCE $1.75
- 52 Week High
- WHWK $3.81
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- WHWK N/A
- GRCE N/A
- Support Level
- WHWK N/A
- GRCE N/A
- Resistance Level
- WHWK N/A
- GRCE N/A
- Average True Range (ATR)
- WHWK 0.00
- GRCE 0.00
- MACD
- WHWK 0.00
- GRCE 0.00
- Stochastic Oscillator
- WHWK 0.00
- GRCE 0.00
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.